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Abstract1
The ongoing functional annotation of proteins relies upon the work of curators to capture2
experimental findings from scientific literature and apply them to protein sequence and3
structure data. However, with the increasing use of high-throughput experimental assays,4
a small number of experimental studies dominate the functional protein annotations col-5
lected in databases. Here we investigate just how prevalent is the “few articles – many6
proteins” phenomenon. We examine the experimentally validated annotation of proteins7
provided by several groups in the GO Consortium, and show that the distribution of pro-8
teins per published study is exponential, with 0.14% of articles providing the source of9
2annotations for 25% of the proteins in the UniProt-GOA compilation. Since each of the10
dominant articles describes the use of an assay that can find only one function or a small11
group of functions, this leads to substantial biases in what we know about the function12
of many proteins. Mass-spectrometry, microscopy and RNAi experiments dominate high13
throughput experiments. Consequently, the functional information derived from these14
experiments is mostly of the subcellular location of proteins, and of the participation15
of proteins in embryonic developmental pathways. For some organisms, the information16
provided by different studies overlap by a large amount. We also show that the informa-17
tion provided by high throughput experiments is less specific than those provided by low18
throughput experiments. Given the experimental techniques available, certain biases in19
protein function annotation due to high-throughput experiments are unavoidable. Know-20
ing that these biases exist and understanding their characteristics and extent is important21
for database curators, developers of function annotation programs, and anyone who uses22
protein function annotation data to plan experiments.23
Author Summary24
Experiments and observations are the vehicles used by science to understand the world25
around us. In the field of molecular biology, we are increasingly relying on high-throughput,26
genome-wide experiments to provide answers about the function of biological macro-27
molecules. However, any experimental assay is essentially limited in the type of infor-28
mation it can discover. Here we show that our increasing reliance on high-throughput29
experiments biases our understanding of protein function. While the primary source of30
information is experiments, the functions of many proteins are computationally annotated31
by sequence-based similarity, either directly or indirectly, to proteins whose function is32
3experimentally determined. Therefore, any biases in experimental annotations can get33
amplified and entrenched in the majority of protein databases. We show here that high-34
throughput studies are biased towards certain aspects of protein function, and that they35
provide less information than low-throughput studies. While there is no clear solution to36
the phenomenon of bias from high-throughput experiments, recognizing its existence and37
its impact can help take steps to mitigate its effect.38
Introduction39
Functional annotation of proteins is an open problem and a primary challenge in molecular40
biology today [1–4]. The ongoing improvements in sequencing technology have shifted41
the emphasis shifting from realizing the $1,000 genome to realizing the 1-hour genome [5].42
The ability to rapidly and cheaply sequence genomes is creating a flood of sequence43
data, but to make these data useful, extensive analysis is needed. A large portion of44
this analysis involves assigning biological function to newly determined gene sequences,45
a process that is both complex and costly [6]. To aid current annotation procedures and46
improve computational function prediction algorithms, high-quality and experimentally47
derived data are necessary. Currently, one of the few repositories of such data is the48
UniProt-GOA database [7], which is a compilation of data contributed by several member49
groups of the GO consortium. UniProt-GOA contains functional information derived50
from literature, and by computational means. The information derived from literature is51
extracted by human curators who capture functional data from publications, assign the52
data to their appropriate place in the Gene Ontology hierarchy [8] and label them with53
appropriate functional evidence codes. UniProt-GOA is compiled from annotations made54
by several member groups of the GO consortium, and as such presents the current state of55
4our view of protein function space. It is therefore important to understand any trends and56
biases that are encapsulated in UniProt-GOA, as those impact well-used sister databases57
and consequently a large number of users worldwide.58
One concern surrounding the capture of functional data from articles is the propensity59
for high-throughput experimental work to become a large fraction of the data in the GO60
Consortium database, thus having a small number of experiments dominate the protein61
function landscape. In this work we analyzed the relative contribution of peer-reviewed62
articles describing all the experimentally derived annotations in UniProt-GOA. We found63
some striking trends, stemming from the fact that a small fraction of articles describing64
high-throughput experiments disproportionately contribute to the pool of experimental65
annotations of model organisms. Consequently we show that: 1) annotations coming66
from high-throughput experiments are overall less informative than those provided by67
low-throughput experiments; 2) annotations from high-throughput experiments are biased68
towards a limited number of functions, and, 3) many high-throughput experiments overlap69
in the proteins they annotate, and in the annotations assigned. Taken together, our70
findings offer a picture of how the protein function annotation landscape is generated71
from scientific literature. Furthermore, due to the biases inherent in the current system72
of sequence annotations, this study serves as a caution to the producers and consumers73
of biological data from high-throughput experiments.74
Results75
Articles and Proteins76
The increase in the number of high-throughput experiments used to determine protein77
functions may introduce biases into experimental protein annotations, due to the inher-78
5ent capabilities and limitations of high-throughput assays. To test the hypothesis that79
such biases exist, and to study their extent if they do, we compiled the details of all80
experimentally annotated proteins in UniProt-GOA. This included all proteins whose GO81
annotations have the GO experimental evidence codes EXP, IDA, IPI, IMP, IGI, IEP (See82
Methods for an explanation of GO evidence codes). We first examined the distribution83
of articles that are the source of experimentally validated annotations by the number of84
proteins they annotate. As can be seen in Figure 1, the distribution of the number of85
proteins annotated per article follows a power-law distribution. f(x) = axk. Using lin-86
ear regression over the log values of the axes we obtained a fit with p < 1.18× 10−8 and87
R2 = −0.72. We therefore conclude that there is indeed a substantial bias in experimental88
annotations, in which there are few articles that annotate a large number of proteins.89
To better understand the consequences of such a distribution, we divided the anno-90
tating articles into four cohorts, based on the number of proteins each article annotates.91
Single-throughput articles are those articles that annotate only one protein; low through-92
put articles annotate 2-9 proteins; moderate throughput articles annotate 10-99 proteins93
and high throughput articles annotate over 99 proteins. The results are shown in Table 1.94
The most striking finding is that high throughput articles are responsible for 25% of the95
annotations that the GO Consortium creates, even though they are found only in 0.14% of96
the articles. 96% of the articles are single-throughput and low-throughput, however those97
annotate only 53% of the proteins. So while moderate-throughput and high-throughput98
studies account for almost 47% of the annotations in Uniprot-GOA, they constitute only99
3.66% of the studies published.100
To understand how the log-odds distribution affects our understanding of protein func-101
tion, we examined different aspects of the annotations in the four article cohorts. Also,102
we examined in greater detail the top-50 high-throughput annotating articles. “Top-50103
6high throughput annotating articles” are the articles describing experimental annotations104
that are top ranked by the number of proteins annotated per article. An initial charac-105
terization of these articles is shown in Table S1. As can be seen, most of the articles are106
specific to a single species (typically a model organism) and to a single assaying pipeline107
that is used to assign function to the proteins in that organism. With one exception, only108
one ontology of the three GO ontologies was used for annotation in any single experiment.109
The three ontologies are Molecular Function (MF), Biological Process (BP) and Cellular110
Component (CC). These are separate ontologies within GO, describing different aspects111
of function as detailed in [8]. As we show later, for some species this means that a single112
functional aspect (MF, BP or CC) of a species can be dominated by a single study.113
The Impact of High Throughput Studies on the Annotation of114
Model Organisms115
We examined the relative contribution of the top-50 articles to the entire corpus of ex-116
perimentally annotated proteins in each species. Unsurprisingly, all the species found in117
the top-50 articles were either common model organisms or human. For each species,118
we examined the five most frequent terms in the top-50 articles. We then examined119
the contribution of this term by the top-50 articles to the general annotations of that120
species. The contribution is the number of annotations by any given GO term in the121
top 50 articles divided by the number of annotations by that GO term in all of UniProt-122
GOA. For example, as seen in Figure 2 in D. melanogaster 88% of the annotations using123
the term “precatalytic splicosome” in articles experimentally annotating this species are124
contributed by the top-50 articles.125
For most organisms annotated by the top-50 articles, the annotations were within the126
7cellular component or biological process ontologies. Notable exceptions areD. melanogaster127
and C. elegans where the dominant terms were from the Biological Process ontology, and128
in mouse, where “protein binding” and “identical protein binding” are from the Molecular129
Function Ontology. D. melanogaster ’s annotation for the top terms is dominated (over130
50% contribution) by the top-50 articles.131
The term frequency bias described here can be viewed more broadly within the ontol-132
ogy bias. The proteins annotated by the cohorts of single-protein articles, low-throughput133
articles, and moderate-throughput articles have similar ratios of the fraction of proteins134
annotated. Twenty-two to twenty-six percent of assigned terms are in the Molecular135
Function Ontology, and 51-57% are in the Biological Process Ontology and the remaining136
17-25% are in the Cellular Component ontology. These ratios change dramatically with137
high-throughput articles (over 99 terms per article). In the high-throughput articles, only138
5% of assigned terms are in the Molecular Function Ontology, 38% in the Biological Pro-139
cess Ontology and 57% in the Cellular Compartment Ontology, ostensibly due to a lack of140
high-throughput assays that can be used for generating annotations using the Molecular141
Function Ontology.142
Repetition and Consistency in Top-50 Annotations143
How many of the top-50 articles actually annotate the same set of proteins? Answering144
this question will tell us how repetitive experiments are in identifying the same set of145
proteins to annotate. However, even when annotating the same set of proteins and within146
the same ontology, different experiments may provide different results, lacking consistency.147
Therefore, the annotation consistency was also checked. Repetition is given as n
N
with n148
being the number of proteins annotated by two or more articles, and N being the total149
number of proteins. The results of the repetition analysis are shown in Figure 3 and in150
8Table 2. As can be seen, the highest repetition (65%) is in the 12 articles annotating151
C. elegans. Of course, a higher number of articles is expected to increase repetitive152
annotations simply due to increased sampling of the genome. However, the goal of this153
analysis is to present the degree of repetition, rather than to try to rank and normalize154
it. As an additional repetition metric, Table 2 also lists the mean number of sequences155
per cluster. When normalized by number of annotating articles, the highest repetition156
is found in Mouse (15.33% in three articles) closely followed by M. tuberculosis (14% in157
two articles). Taken together, these results show that there is repetition in choosing the158
proteins that are to be annotated in most model organisms using high-throughput assays,159
although the rate of this repetition varies widely.160
Consistency analysis took place as described in Methods. The consistency measure161
is normalized on a 0-1 scale, with 1 being most consistent, meaning that all annotations162
from all sources are identical. Table 3 shows the results of this analysis. In A. thaliana,163
1941 proteins are annotated by 15 articles and 18 terms in the Cellular Component on-164
tology. The mean maximum-consistency is 0.251. The highest mean consistency is for165
the annotation of 807 mouse proteins annotated in Cellular Component ontology with166
an annotation consistency 0.832. However, that is not surprising given that there are167
only three annotating articles, and two annotating terms. We omitted the ontology and168
organism combinations that were annotated by less than three articles or two GO terms,169
or both.170
Quantifying Annotation Information171
A common assumption holds that while high-throughput experiments do annotate more172
protein functions than low-throughput experiments, the former also tend to be more173
shallow in the predictions they provide. The information provided, for example, by a174
9large-scale protein binding assay will only tell us if two proteins are binding, but will175
not reveal whether that binding is specific, will not provide an exact Kbind, will not say176
under what conditions binding takes place, or whether there is any enzymatic reaction177
or signal-transduction involved. Having on hand data from experiments with different178
“throughputness” levels, we set out to investigate whether there is indeed a difference in179
the information provided by high-throughput experiments vs. low-throughput ones. We180
examined the information provided by GO terms in each paper cohort using two methods:181
edge-count, and information-content. See Methods for details.182
The results of both analyses are shown in Figure 4. In general, the results from the183
edge count analysis and the information-content based analysis are in agreement when184
compared across annotation cohorts. For the Molecular Function ontology, the distribu-185
tion of edge counts and log-frequency scores decreases as the number of annotated proteins186
per-article increases. For the Biological Process ontology, the decrease is significant. How-187
ever the contributors to the decrease are the high-throughput articles while there is little188
change in the first three article cohorts. Finally, there is no significant trend of GO-depth189
decrease in the Cellular Component Ontology. However, using the information-content190
metric, there is also a significant decrease in information-content in the high-throughput191
article cohort.192
Exclusive High Throughput Annotations193
Of interest is the fraction of proteins that are exclusively annotated by high-throughput194
experiments. The question here is: from the experimentally annotated proteins in an or-195
ganism, how much do we know of their function only using high-throughput experiments?196
We have seen that high-throughput experiments annotate a large number of proteins, but197
still some 80% of experimentally determined proteins are annotated via medium-, low- and198
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single-throughput experiments. Given the lower information-content of high-throughput199
experiments, it is important to know which organisms have a substantial fraction of the200
proteins experimentally annotated by high throughput studies only. To do so, we ana-201
lyzed all species with more than 200 genes in the NCBI taxa database for the fraction202
of the genes that are exclusively annotated by high throughput studies. The results are203
shown in Table 4.204
As can be seen, although the fraction of high-throughput annotated proteins is large,205
not many species are affected with a large fraction of proteins that are exclusively anno-206
tated by high-throughput studies. However, the few species that are affected are important207
study and model species. It is important to note that some redundancy due to isoforms,208
mutants and duplications may exist.209
Frequently Used High-Throughput Experiments210
The twenty GO evidence codes, discussed above, encapsulate the means by which the211
function was inferred, but they do not capture all the necessary information. For example,212
“Inferred by Direct Assay” (IDA) informs that some experimental assay was used, but213
does not say which type of assay. This information is often needed, since knowing which214
experiments were performed can help the researcher establish the reliability and scope215
of the produced data. RNA, used in an RNAi experiment does not traverse the blood-216
brain-barrier, meaning that no data from the central nervous system can be drawn from an217
RNAi experiment. The Evidence Code Ontology, or ECO, seeks to improve upon the GO-218
attached evidence codes. ECO provides more elaborate terms than “Inferred by Direct219
Assay”: ECO also conveys which assay was used, for example “microscopy” or “RNA220
interference”. In addition to evidence terms, the ECO ontology provides assertion terms221
in which the nature of the assay is given. For example, an enzyme-linked immunosorbent222
11
assay (ELISA) provides quantitative protein data in vitro while an immunogold assay may223
provide the same information, and cellular localization information in situ. We manually224
assigned Evidence Codes Ontology (ECO) assertion and evidence terms to the top-50225
articles. The assignment is shown in detail in Table S2. Table S3 shows the sorted count226
of ECO terms in the top-50 papers.227
The most frequent ECO term used is ECO:0000160 “protein separation followed by228
fragment identification evidence”: this fits the 27 papers that essentially describe mass-229
spectrometry studies. Consequently this means that the assignment procedure is limited230
to the cellular compartments that can be identified with the fractionation methods used.231
So while Cellular Component is the most frequent annotation used, fractionation and232
mass-spectrometry is the most common method used to localize proteins in subcellu-233
lar compartments. A notable exception to the use of fractionation and MS for protein234
localization is in the top annotating article [9], which uses microscopy for subcellular235
localization.236
The second most frequent experimental ECO term is “Imaging assay evidence” (ECO:000044).237
Several types of studies fall under this ECO. Those include microscopy, RNAi, some of the238
mass-spectrometry studies that used microscopy, and a yeast-2-hybrid study. As imaging239
information is used in a variety of studies, this ECO term is not informative of the chief240
method used in any study, but rather the importance of imaging assays in a variety of241
methods. The third most frequent experimental ECO term used was “Cell fractionation242
evidence” which is closely associated with the top term, “Imaging assay evidence”. The243
fourth annd fifth most frequent ECO term used were “loss-of-function mutant phenotype244
evidence” (ECO:0000016) and “RNAi evidence” (ECO:000019). These two terms are also245
closely associated, in RNAi whole-genome gene knockdowns in C. elegans, D. melanogaster246
and one in C. albicans. RNAi experiments use targeted dsRNA which is delivered to the247
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organism and silences specific genes. Typically the experiments here used libraries of248
RNAi targeted to the whole exome (for example [10–13]). The phenotypes searched for249
were mostly associated with embryonic and post-embryonic development. Some studies250
focused on mitotic spindle assembly [14], lipid storage [15] and endocytic traffic [16]. One251
study used RNAi to identify mitochondrial protein localization [17]. These studies mostly252
use the same RNAi libraries, and target the whole C. elegans genome using common data253
resources. Hence the large redundancy observed for C. elegans in Table 2. It should be254
noted that all experiments are associated with computational ECO terms, which describe255
sequence similarity and motif recognition techniques used to identify the sequences found:256
“sequence similarity evidence”, “transmembrane domain prediction evidence”, “protein257
BLAST evidence” etc. These terms are all bolded in Table S3. A strong reliance on258
computational annotation is therefore an integral part of high throughput experiments.259
It should be noted that computational annotation here is not used directly for functional260
annotation, but rather for identifying the protein by a sequence or motif similarity search.261
The third most frequently used assertion in the top experimental articles was not an exper-262
imental assertion, but rather a computational one: the term ECO:00053 “computational263
combinatorial evidence” is defined as “A type of combinatorial analysis where data are264
combined and evaluated by an algorithm.” This is not a computational prediction per se,265
but rather a combination of several experimental lines of evidence used in a article.266
Discussion267
We have identified several annotation biases in GO annotations provided by the GO268
consortium. These biases stem from the uneven number of annotations produced by dif-269
ferent types of experiments. It is clear that results from high-throughput experiments270
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contribute substantially to the function annotation landscape, as up to 20% of experi-271
mentally annotated proteins are annotated by high-throughput assays. At the same time,272
high throughput experiments produce less information per protein than moderate–, low–273
and single– throughput experiments as evidenced by the type of GO terms produced in274
the Molecular Function and Biological Process ontologies. Furthermore, the number of275
total GO terms used in the high-throughput experiments is much lower than that used in276
low and medium throughput experiments. Therefore, while high throughput experiments277
provide a high coverage of protein function space, it is the low throughput experiments278
that provide more specific information, as well as a larger diversity of terms.279
We have also identified several types of biases that are contributed by high throughput280
experiments. First, there is the enrichment of low-information-content GO terms, which281
means that our understanding of the protein function as provided by high-throughput282
experiments is more limited than that provided by low-throughput experiments. Second,283
there is the small number of terms used, when considering the large number of proteins284
that are being annotated. Third is the general ontology bias towards the cellular com-285
ponent ontology and, to a lesser extent, the Biological Process ontology: there are very286
few articles that deal with the Molecular Function ontology. These biases all stem from287
the inherent capabilities and limitations of the hight-throughput experiments. A fourth,288
related bias is the organism studied: taken together, studies of C. elegans and A. thaliana289
studies comprise 36 of the top-50 annotating articles, or 72%.290
Information Capture and Scope of GO291
We have discussed the information loss that is characteristic of high-throughput experi-292
ments, as shown in Figure 4. However, another reason for information loss is the inability293
to capture certain types of information using the Gene Ontology. GO is purposefully294
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limited to three aspects (MF, BP and CC) of biological function, which are assigned per295
protein. However, other aspects of function may emerge from experiments. Of note is296
the study, “Proteome survey reveals modularity of the yeast cell machinery” [9]. In this297
study, the information produced was primarily of protein complexes, and the relationship298
to cellular compartmentalization and biological networks. At the same time, the only GO299
term captured in the curation of proteins from this study was “protein binding”. Some,300
but not all of this information can be captured more specifically using the children of301
the term “protein binding”, but such a process is arguably laborious by manual curation302
of the information from a high throughput article. Furthermore, the main information303
conveyed by this article, namely the types of protein complexes discovered and how they304
relate to cellular networks, is outside the scope of GO. It is important to realize that while305
high-throughput experiments do convey less information per protein within the functional306
scope as defined by GO, they still convey composite information such as possible pathway307
mappings – information which needs to be captured into annotation databases by means308
other than GO. In the example above, the information can be captured by a protein in-309
teraction database, but not by GO terms. Methods such as the Statistical Tracking of310
Ontological Phrases [18] can help in selecting the appropriate ontology for better infor-311
mation capture.312
Conclusions313
Taken together, the annotation trends in high-throughput studies affect our understand-314
ing of protein function space. This, in turn, affects our ability to properly understand the315
connection between predictors of protein function and the actual function – the hallmark316
of computational function annotation. As a dramatic example, during the 2011 Critical317
Assessment of Function Annotation experiment [19] it was noticed that roughly 20% of318
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the proteins participating in the challenge and annotated with the Molecular Function319
Ontology were annotated as “protein binding”, a GO term that conveys little informa-320
tion. Furthermore, it was shown that the major contribution of “protein binding” term321
to the CAFA challenge data set was due to high-throughput assays. This illustrates how322
the concentration of a large number of annotations in a small number of studies provides323
only a partial picture of the function of these proteins. As we have seen, the picture324
provided from high throughput experiments is mainly of: 1) subcellular localization cell325
fractionation and MS based localization and 2) developmental phenotypes. While these326
data are important, we should be mindful of this bias when examining protein function in327
the database, even those annotations deemed to be of high quality, those with experimen-328
tal verification. Furthermore, such a large bias in prior probabilities can adversely affect329
programs employing prior probabilities, as most machine-learning programs do. If the330
training set for these programs has included a disproportional number of annotations by331
high-throughput experiments, the results these programs provide will be strongly biased332
towards a few frequent and shallow GO terms.333
To remedy the bias created by high throughput annotations, the provenance of an-334
notations should be described in more detail by curators and curation software. Many335
function annotation algorithms rely on homology transfer as part of their pipeline to an-336
notate query sequences [1,19]. Knowing the annotation provenance, including the number337
of proteins annotated by the original paper can create less biased benchmarks or otherwise338
incorporate that information into the annotation procedure. The ECO ontology can be339
used to determine the source of the annotation, and the user or the algorithm can decide340
whether to rely upon any combinations of “throughputness” and experimental type. Of341
course, such approaches should be taken cautiously, as sweeping measures can cause the342
unintended loss of information. We hereby call upon the communities of annotators, com-343
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putational biologists and experimental biologists to be mindful of the phenomenon of the344
experimental biases described in this study, and to work to understand its implications345
and impact.346
Methods347
We used the UniProt-GOA database from December 2011. Data analyses were performed348
using Python scripts. The following tools were used in the analyses: Biopython [20], mat-349
plotlib [21]. ECO terms classifying the proteins in the top 50 experiments were assigned350
to the proteins manually after reading the articles. All data and scripts are available on:351
http://github.com/idoerg/Uniprot-Bias/ and on http://datadryad.org (the latter upon352
acceptance).353
Use of GO evidence codes354
Proteins in UniProt-GOA are annotated with one or more GO terms using a procedure355
described in Dimmer et al. (2012). Briefly, this procedure consists of six steps which356
include sequence curation, sequence motif analyses, literature-based curation, reciprocal357
BLAST [22] searches, attribution of all resources leading to the included findings, and358
quality assurance. If the annotation source is a research article, the attribution includes359
its PubMed ID. For each GO term associated with a protein, there is also an evidence code360
which the curator assigns to explain how the association between the protein and the GO361
term was made. Experimental evidence codes include such terms as: Inferred by Direct As-362
say (IDA) which indicates that “a direct assay was carried out to determine the function,363
process, or component indicated by the GO term” or Inferred from Physical Interaction364
(IPI) which “Covers physical interactions between the gene product of interest and another365
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molecule.” (All GO evidence code definitions were taken from the GO site, geneontol-366
ogy.org.) Computational evidence codes include terms such as Inferred from Sequence or367
Structural Similarity (ISS) and Inferred from Sequence Orthology (ISO). Although the ev-368
idence in computational evidence codes is non-experimental, the proteins annotated with369
these evidence codes are still assigned by a curator, rendering a degree of human oversight.370
Finally, there are also computational, non-experimental evidence codes, the most preva-371
lent being Inferred from Electronic Annotation (IEA) which is “used for annotations that372
depend directly on computation or automated transfer of annotations from a database”.373
IEA evidence means that the annotation is electronic, and was not made or checked by a374
person. Different degrees of reliability are associated with different evidence codes, with375
experimental codes generally considered to be of higher reliability than non-experimental376
codes. (For details see: http://www.ebi.ac.uk/GOA/ElectronicAnnotationMethods)377
Quantifying GO-term Information378
We used two methods to quantify the information given by GO terms. First we used379
edge counting , where the information contained in a term is dependent on the edge380
distance of that term from the root. The term “catalytic activity”(one edge distance381
from the ontology root node) would be less informative than “hydrolase activity” (two382
edges) and the latter will be less informative than “haloalkane dehalogenase activity”383
(five edges). We therefore counted edges from the ontology root term to the GO term384
to determine term information. The larger the number of edges, the more specific –and385
therefore informative– is the annotation. In cases where several paths lead from the root386
to the examined GO term, we used the minimal path. We did so for all the annotating387
articles split into groups by the number of proteins each article annotates.388
While edge counting provides a measure of term-specificity, this measure is imperfect.389
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The reason is that each of the three GO ontologies is constructed as a directed acyclic390
graph (DAG) where different areas of the GO DAG have different connectivities, and terms391
may have different depths unrelated to the intuitive specificity of a term. For example “D-392
glucose transmembrane transporter activity”, (GO:0055056) is 10 terms deep, while “L-393
tryptophan transmembrane transporter activity”, (GO:0015196) is fourteen terms deep.394
It is hard to discern whether these differences are meaningful. For this reason, information395
content, the logarithm of the inverse of the GO term frequency in the corpus, is generally396
accepted as a measure of GO term information content [23,24]. To account for the possible397
bias created by the GO-DAG structure, we also used the log-frequency of the terms in398
the experimentally annotated proteins in Uniprot-GOA. However, it should be noted that399
the log-frequency measure is also imperfect because, as we see throughout this study, a400
GO term’s frequency may be heavily influenced by the top annotating articles, injecting401
a circularity problem into the use of this metric. Since no single metric for measuring the402
information conveyed by a GO term is wholly satisfactory, we used both edge-counting403
and information-content in this study.404
Annotation Consistency405
To examine annotation consistency, we employed the following method: given a protein406
P , let G be the terminal (leaf) GO terms g1, g2, . . . , gm that annotate that protein in all407
top-50 articles for a single ontology O ∈ {BPO,MFO,CCO}. The count of each of these408
GO terms per protein per ontology is n1, n2, . . . , nm with ni being the number of times409
GO term gi annotates protein P .410
The number of total annotations for a protein in an ontology is
∑m
1
ni . The maximum411
annotation consistency for protein P in ontology O 0 ≤ kP,O ≤ 1 is calculated as:412
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kP,O =
max(n1, n2, . . . , nm)∑m
ni
for max(n1, n2, . . . , nm) ≥ 2
For example, the protein “Oleate activated transcription factor 3” (UniProtID: P36023)413
in S. cerevisiae is annotated four times by three articles using the Cellular Component414
ontology:415
PubMedID UniProt ID Ontology GO term description
14562095 P36023 CCO GO:0005634 nucleus
14562095 P36023 CCO GO:0005737 cytoplasm
16823961 P36023 CCO GO:0005739 mitochondrion
14576278 P36023 CCO GO:0005739 mitochondrion
The annotation consistency for P36023 is therefore the maximum count of identical416
GO terms (mitochondrion, 2), divided by the total number of annotations, 4: 0.5.417
When choosing a measure for annotation consistency, we favored a simple and inter-418
pretable measure. We therefore examined identity among leaf terms only, rather than419
use a more complex comparison of multiple subgraphs in the GO ontology DAG (Di-420
rected Acyclic Graph). Doing so without manual curation is unreliable, and may skew421
the perception of similarity [25].422
Acknowledgments423
We thank Predrag Radivojac, Nives Sˇkunca, Cristophe Dessimoz, Yanay Ofran, Marc424
Robinson-Rechavi, Wyatt Clark, Tony Sawford, Chris Mungall, Rama Balakrishnan, and425
members of the Friedberg and Babbitt labs for insightful discussions. We are especially426
grateful to Rachael Huntley for careful reading of the manuscript and for providing de-427
tailed explanations of annotation provenance and methodology in UniProt.428
20
Funding429
This research was funded, in part, by NSF DBI 1146960 award to IF and NIH R01430
GM60595 and NSF DBI 0640476 to PCB.431
References432
1. Friedberg I (2006) Automated protein function prediction–the genomic challenge.433
Brief Bioinform 7: 225–242.434
2. Schnoes AM, Brown SD, Dodevski I, Babbitt PC (2009) Annotation error in public435
databases: Misannotation of molecular function in enzyme superfamilies. PLoS436
Comput Biol 5: e1000605+.437
3. Erdin S, Lisewski AM, Lichtarge O (2011) Protein function prediction: towards438
integration of similarity metrics. Current Opinion in Structural Biology 21: 180 -439
188.440
4. Rentzsch R, Orengo CA (2009) Protein function prediction the power of multiplic-441
ity. Trends in Biotechnology 27: 210 - 219.442
5. Sthl PL, Lundeberg J (2012) Toward the single-hour high-quality genome. Annual443
Review of Biochemistry 81: 359-378.444
6. Sboner A, Mu X, Greenbaum D, Auerbach R, Gerstein M (2011) The real cost of445
sequencing: higher than you think! Genome Biology 12: 125+.446
7. Dimmer EC, Huntley RP, Alam-Faruque Y, Sawford T, O’Donovan C, et al. (2012)447
The uniprot-go annotation database in 2011. Nucleic Acids Research 40: D565–448
D570.449
21
8. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology:450
tool for the unification of biology. Nature Genetics 25: 25–29.451
9. Barbe L, Lundberg E, Oksvold P, Stenius A, Lewin E, et al. (2008) Toward a452
confocal subcellular atlas of the human proteome. Mol Cell Proteomics 7: 499–453
508.454
10. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, et al.455
(2000) Functional genomic analysis of C. elegans chromosome I by systematic RNA456
interference. Nature 408: 325–330.457
11. Maeda I, Kohara Y, Yamamoto M, Sugimoto A (2001) Large-scale analysis of gene458
function in Caenorhabditis elegans by high-throughput RNAi. Curr Biol 11: 171–459
176.460
12. Piano F, Schetter AJ, Morton DG, Gunsalus KC, Reinke V, et al. (2002) Gene461
clustering based on RNAi phenotypes of ovary-enriched genes in C. elegans. Curr462
Biol 12: 1959–1964.463
13. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, et al. (2003) Systematic464
functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:465
231–237.466
14. Goshima G, Wollman R, Goodwin SS, Zhang N, Scholey JM, et al. (2007) Genes467
required for mitotic spindle assembly in Drosophila S2 cells. Science 316: 417–421.468
15. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, et al. (2003) Genome-469
wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421:470
268–272.471
22
16. Balklava Z, Pant S, Fares H, Grant BD (2007) Genome-wide analysis identifies472
a general requirement for polarity proteins in endocytic traffic. Nat Cell Biol 9:473
1066–1073.474
17. Hughes JR, Meireles AM, Fisher KH, Garcia A, Antrobus PR, et al. (2008) A475
microtubule interactome: complexes with roles in cell cycle and mitosis. PLoS Biol476
6: e98.477
18. Wittkop T, TerAvest E, Evani U, Fleisch K, Berman A, et al. (2013) STOP using478
just GO: a multi-ontology hypothesis generation tool for high throughput experi-479
mentation. BMC Bioinformatics 14: 53+.480
19. Radivojac P, ClarkW, Ronnen-Oron T, Schnoes A, Wittkop T, et al. (2013) A large-481
scale evaluation of computational protein function prediction. Nature Methods in482
press.483
20. Cock P, Antao T, Chang J, Chapman B, Cox C, et al. (2009) Biopython: freely484
available python tools for computational molecular biology and bioinformatics.485
Bioinformatics 25: 1422.486
21. Hunter JD (2007) Matplotlib: A 2d graphics environment. Computing In Science487
& Engineering 9: 90–95.488
22. Altschul SF, Madden TL, Scha¨ffer AA, Zhang J, Zhang Z, et al. (1997) Gapped489
blast and psi-blast: a new generation of protein database search programs. Nucleic490
acids research 25: 3389–3402.491
23. Lord PW, Stevens RD, Brass A, Goble CA (2003) Investigating semantic simi-492
larity measures across the gene ontology: the relationship between sequence and493
annotation. Bioinformatics 19: 1275–1283.494
23
24. Pesquita C, Faria D, Falca˜o AO, Lord P, Couto FM (2009) Semantic similarity in495
biomedical ontologies. PLoS Comput Biol 5: e1000443+.496
25. Faria D, Schlicker A, Pesquita C, Bastos H, Ferreira AEN, et al. (2012) Mining GO497
annotations for improving annotation consistency. PLoS ONE 7: e40519+.498
26. Matsuyama A, Arai R, Yashiroda Y, Shirai A, Kamata A, et al. (2006) ORFeome499
cloning and global analysis of protein localization in the fission yeast Schizosaccha-500
romyces pombe. Nat Biotechnol 24: 841–847.501
27. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, et al. (2008) A mitochon-502
drial protein compendium elucidates complex I disease biology. Cell 134: 112–123.503
28. Simmer F, Moorman C, van der Linden AM, Kuijk E, van den Berghe PV, et al.504
(2003) Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals505
novel gene functions. PLoS Biol 1: E12.506
29. Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, et al. (2003) Global507
analysis of protein localization in budding yeast. Nature 425: 686–691.508
30. Zybailov B, Rutschow H, Friso G, Rudella A, Emanuelsson O, et al. (2008) Sorting509
signals, N-terminal modifications and abundance of the chloroplast proteome. PLoS510
ONE 3: e1994.511
31. Sonnichsen B, Koski LB, Walsh A, Marschall P, Neumann B, et al. (2005) Full-512
genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature513
434: 462–469.514
24
32. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, et al. (2003)515
Integrated analysis of protein composition, tissue diversity, and gene regulation in516
mouse mitochondria. Cell 115: 629–640.517
33. Benschop JJ, Mohammed S, O’Flaherty M, Heck AJ, Slijper M, et al. (2007) Quan-518
titative phosphoproteomics of early elicitor signaling in Arabidopsis. Mol Cell Pro-519
teomics 6: 1198–1214.520
34. Mawuenyega KG, Forst CV, Dobos KM, Belisle JT, Chen J, et al. (2005) My-521
cobacterium tuberculosis functional network analysis by global subcellular protein522
profiling. Mol Biol Cell 16: 396–404.523
35. Ito J, Batth TS, Petzold CJ, Redding-Johanson AM, Mukhopadhyay A, et al. (2011)524
Analysis of the Arabidopsis cytosolic proteome highlights subcellular partitioning525
of central plant metabolism. J Proteome Res 10: 1571–1582.526
36. Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, et al. (2004) Toward improving527
Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library.528
Genome Res 14: 2162–2168.529
37. Reinders J, Zahedi RP, Pfanner N, Meisinger C, Sickmann A (2006) Toward the530
complete yeast mitochondrial proteome: multidimensional separation techniques531
for mitochondrial proteomics. J Proteome Res 5: 1543–1554.532
38. Fernandez-Calvino L, Faulkner C, Walshaw J, Saalbach G, Bayer E, et al. (2011)533
Arabidopsis plasmodesmal proteome. PLoS ONE 6: e18880.534
39. Gu S, Chen J, Dobos KM, Bradbury EM, Belisle JT, et al. (2003) Comprehensive535
proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis536
strain. Mol Cell Proteomics 2: 1284–1296.537
25
40. Ferro M, Brugiere S, Salvi D, Seigneurin-Berny D, Court M, et al. (2010)538
ATCHLORO, a comprehensive chloroplast proteome database with subplastidial539
localization and curated information on envelope proteins. Mol Cell Proteomics 9:540
1063–1084.541
41. Kleffmann T, Russenberger D, von Zychlinski A, Christopher W, Sjolander K, et al.542
(2004) The Arabidopsis thaliana chloroplast proteome reveals pathway abundance543
and novel protein functions. Curr Biol 14: 354–362.544
42. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth545
defined by high density mutagenesis. Mol Microbiol 48: 77–84.546
43. Mitra SK, Gantt JA, Ruby JF, Clouse SD, Goshe MB (2007) Membrane proteomic547
analysis of Arabidopsis thaliana using alternative solubilization techniques. J Pro-548
teome Res 6: 1933–1950.549
44. Ceron J, Rual JF, Chandra A, Dupuy D, Vidal M, et al. (2007) Large-scale RNAi550
screens identify novel genes that interact with the C. elegans retinoblastoma path-551
way as well as splicing-related components with synMuv B activity. BMC Dev Biol552
7: 30.553
45. Sickmann A, Reinders J, Wagner Y, Joppich C, Zahedi R, et al. (2003) The pro-554
teome of Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci USA 100:555
13207–13212.556
46. Gavin AC, Aloy P, Grandi P, Krause R, Boesche M, et al. (2006) Proteome survey557
reveals modularity of the yeast cell machinery. Nature 440: 631–636.558
26
47. Green RA, Kao HL, Audhya A, Arur S, Mayers JR, et al. (2011) A high-resolution559
C. elegans essential gene network based on phenotypic profiling of a complex tissue.560
Cell 145: 470–482.561
48. Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S (2000) Sys-562
tematic subcellular localization of novel proteins identified by large-scale cDNA563
sequencing. EMBO Rep 1: 287–292.564
49. Marmagne A, Ferro M, Meinnel T, Bruley C, Kuhn L, et al. (2007) A high content565
in lipid-modified peripheral proteins and integral receptor kinases features in the566
arabidopsis plasma membrane proteome. Mol Cell Proteomics 6: 1980–1996.567
50. Dunkley TP, Hester S, Shadforth IP, Runions J, Weimar T, et al. (2006) Mapping568
the Arabidopsis organelle proteome. Proc Natl Acad Sci USA 103: 6518–6523.569
51. Jaquinod M, Villiers F, Kieffer-Jaquinod S, Hugouvieux V, Bruley C, et al. (2007)570
A proteomics dissection of Arabidopsis thaliana vacuoles isolated from cell culture.571
Mol Cell Proteomics 6: 394–412.572
52. Heazlewood JL, Tonti-Filippini JS, Gout AM, Day DA, Whelan J, et al. (2004) Ex-573
perimental analysis of the Arabidopsis mitochondrial proteome highlights signaling574
and regulatory components, provides assessment of targeting prediction programs,575
and indicates plant-specific mitochondrial proteins. Plant Cell 16: 241–256.576
53. Carter C, Pan S, Zouhar J, Avila EL, Girke T, et al. (2004) The vegetative vacuole577
proteome of Arabidopsis thaliana reveals predicted and unexpected proteins. Plant578
Cell 16: 3285–3303.579
27
54. Da Cruz S, Xenarios I, Langridge J, Vilbois F, Parone PA, et al. (2003) Proteomic580
analysis of the mouse liver mitochondrial inner membrane. J Biol Chem 278: 41566–581
41571.582
55. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005)583
Towards a proteome-scale map of the human protein-protein interaction network.584
Nature 437: 1173–1178.585
56. Bakthavatsalam D, Gomer RH (2010) The secreted proteome profile of developing586
Dictyostelium discoideum cells. Proteomics 10: 2556–2559.587
57. Froehlich JE, Wilkerson CG, Ray WK, McAndrew RS, Osteryoung KW, et al.588
(2003) Proteomic study of the Arabidopsis thaliana chloroplastic envelope mem-589
brane utilizing alternatives to traditional two-dimensional electrophoresis. J Pro-590
teome Res 2: 413–425.591
58. Stroschein-Stevenson SL, Foley E, O’Farrell PH, Johnson AD (2006) Identification592
of Drosophila gene products required for phagocytosis of Candida albicans. PLoS593
Biol 4: e4.594
59. Rutschow H, Ytterberg AJ, Friso G, Nilsson R, van Wijk KJ (2008) Quantitative595
proteomics of a chloroplast SRP54 sorting mutant and its genetic interactions with596
CLPC1 in Arabidopsis. Plant Physiol 148: 156–175.597
60. Kumar A, Agarwal S, Heyman JA, Matson S, Heidtman M, et al. (2002) Subcellular598
localization of the yeast proteome. Genes Dev 16: 707–719.599
61. Gonczy P, Echeverri C, Oegema K, Coulson A, Jones SJ, et al. (2000) Functional600
genomic analysis of cell division in C. elegans using RNAi of genes on chromosome601
III. Nature 408: 331–336.602
28
62. Suzuki H, Fukunishi Y, Kagawa I, Saito R, Oda H, et al. (2001) Protein-protein603
interaction panel using mouse full-length cDNAs. Genome Res 11: 1758–1765.604
63. Sarry JE, Kuhn L, Ducruix C, Lafaye A, Junot C, et al. (2006) The early re-605
sponses of Arabidopsis thaliana cells to cadmium exposure explored by protein and606
metabolite profiling analyses. Proteomics 6: 2180–2198.607
64. Chen D, Toone WM, Mata J, Lyne R, Burns G, et al. (2003) Global transcriptional608
responses of fission yeast to environmental stress. Mol Biol Cell 14: 214–229.609
65. Herold N, Will CL, Wolf E, Kastner B, Urlaub H, et al. (2009) Conservation of the610
protein composition and electron microscopy structure of Drosophila melanogaster611
and human spliceosomal complexes. Mol Cell Biol 29: 281–301.612
66. Bayer EM, Bottrill AR, Walshaw J, Vigouroux M, Naldrett MJ, et al. (2006) Ara-613
bidopsis cell wall proteome defined using multidimensional protein identification614
technology. Proteomics 6: 301–311.615
29
Figures616
Figure 1. Distribution of the number of proteins annotated per article.
X-axis: number of annotating articles. Y-axis: number of annotated proteins. The
distribution was found to be logarithmic with a significant (R2 = 0.72; p < 1.10× 10−18)
linear fit to the log-log plot. The data came from 76137 articles annotating 256033
proteins with GO experimental evidence codes, in Uniprot-GOA 12/2011.
30
Figure 2. Relative contribution of top-50 articles to the annotation of major
model organisms. The length of each bar represents the percentage of proteins
annotated by the top-50 articles in a given organism by a given GO term. GO terms
that are present in more than one species are highlighted.
31
Figure 3. Redundancy in proteins described by the top-50 articles. A circle
represents the sum total of articles annotating each organism. Each colored arch is
composed of all the proteins in a single article. A line is drawn between any two points
on the circle if the proteins they represent have 100% sequence identity. A black line is
drawn if they are annotated with a different ontology (for example, in one article the
protein is annotated with the MFO, and in another article with BPO); a red line if they
are annotated in the same ontology. Example: S. pombe is described by two articles, one
with few protein (light arch on bottom) and one with many (dark arch encompassing
most of circle). Many of the same proteins are annotated by both articles. See Table 2
for numbers.
32
MF=1 <10 <100 >100    BP=1 <10 <100 >100    CC=1 <10 <100 >100
Study Cohort and Ontology
0
2
4
6
8
10
12
In
fo
rm
at
io
n 
Co
nt
en
t
33
4B617
MF=1 <10 <100 >100    BP=1 <10 <100 >100    CC=1 <10 <100 >100
Study Cohort and Ontology
2
4
6
8
10
12
14
GO
 D
ep
th
Figure 4. Information provided by articles depending on the number of
proteins the articles annotate. Articles are grouped into cohorts: 1: one protein
annotated by article; < 10: more than 1, up to 10 annotated; < 100: more than 10, less
than 100 annotated; ≥ 100: 100 or more proteins annotated per article. Blue bars:
Molecular Function ontology; Green bars: Biological Process ontology; Red bars:
Cellular Component ontology. Information is gauged by A: Information Content and B:
GO depth. See text for details.
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Tables619
Table 1. Annotation Cohorts
Articles annotating the
following number of pro-
teins
1 1 < n < 10 10 ≤ n < 100 n ≥ 100 SUM
Number of proteins an-
notated
20699 46383 26485 31411 124978
Number of annotating
articles
41156 32201 2672 108 76137
Percent of proteins an-
notated
16.56 37.11 21.19 25.13 100
Percent of annotating
articles
54.09 42.32 3.51 0.14 100
Number of proteins and annotating articles assigned to each article annotation cohort.
Columns: 1: articles annotating a single protein (singletons); 1 < n < 10 articles
annotating more than 1 and less than 10 proteins (low throughput); 10 ≤ n < 100:
medium throughput; n ≥ 100: articles annotating 100 proteins and more (high
throughput). As can be seen, high-throughput articles comprise 0.14% of the total
articles used for experimental annotations, but annotate 25.13% of the proteins in
UniProt-GOA.
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Table 2. Sequence Redundancy in Top-50 Annotating Articles
Species num.
articles
num.
prot
Clusters
at 100%
% redun-
dancy
Mean
genes/
cluster
C. elegans 12 8416 3338 60 3.74
A. thaliana 16 8879 4694 47 3.92
M. musculus 3 4220 2273 46 2.75
M. tuberculosis 2 2351 1702 28 2.22
S. cerevisiae 5 3542 2550 28 2.33
H. sapiens 4 5593 4509 19 2.36
D. melanogaster 3 1217 1003 18 2.17
S. pombe 2 4502 4281 5 2.00
Species: annotated species; num. articles number of annotating articles; num. prot:
number of proteins annotated by top-50 articles for that species; Clusters at 100%:
number of clusters of 100% identical proteins; % redundancy: the product of column 4
by column 3: this is the percentage of proteins annotated more than once for a given
species in the top 50 articles; Mean genes/cluster: the mean number of genes per
cluster, for clusters having more than a single gene.
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Table 3. Annotation Consistency in Top 50 articles
Species Ont. num prot mean kP,O stdv stderr num
articles
num
terms
A. thaliana CCO 1941 0.251 0.328 0.007 15 18
C. elegans BPO 1847 0.388 0.239 0.006 12 41
D. melanogaster BPO 76 0.086 0.22 0.025 3 8
D. melanogaster CCO 81 0.068 0.234 0.026 3 5
H. sapiens CCO 167 0.285 0.365 0.028 2 20
M. musculus CCO 807 0.832 0.291 0.01 3 2
S. cerevisiae CCO 744 0.759 0.379 0.014 4 15
B. tuberculosis CCO 532 0.309 0.41 0.018 2 3
Species: annotated species; Ontology: annotating GO ontology; num prot: number
of annotated proteins in that species & ontology that are annotated by more than one
paper. mean, stdv, stderr: mean number of consistent annotations for a protein in
that species and ontology, standard deviation from the mean and standard error. num
articles: number of annotating articles num terms number of annotating terms.
Annotations by less than two articles or two terms (or both) for the same
protein/ontology combination have been omitted.
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Table 4. Fraction of Proteins Exclusively Annotated by High Throughput
Studies
Taxon ID Taxon XHT Total Proteins %XHT
284812 Schizosaccharomyces pombe 2781 4507 61.704
1773 Bacillus tuberculosis 1224 2317 52.8269
6239 Caenorhabditis elegans 2493 5302 47.02
9606 Homo sapiens 4016 11521 34.8581
44689 Dictyostelium discoideum 425 1256 33.8376
3702 Arabidopsis thaliana 3199 10153 31.5079
237561 Candida albicans SC5314 327 1243 26.3073
10090 LK3 transgenic mice 2567 22068 11.6322
7227 Drosophila melanogaster 735 7501 9.7987
559292 Saccharomyces cerevisiae 439 5086 8.6315
83333 Escherichia coli K-12 83 1606 5.1681
7955 Brachidanio rerio 117 4633 2.5254
10116 Buffalo rat 11 4634 0.2374
Taxon ID: NCBI Taxon ID number; Species: annotated species; XHT: number of
proteins exclusively annotated by high-throughput experimental studies (100 or more
proteins annotated per study); Total proteins: Total number of experimentally
annotated proteins in that species. %XHT: percentage of proteins in that species that
are annotated exclusively by HT studies.
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Supplementary Material Legends620
Table S1: The top 50 annotating articles.621
N: article rank; Proteins: number of proteins annotated in this article; Annotations:622
number of annotating GO terms; Species: annotated species; ref. annotating article;623
MFO/BPO/CCO: number of proteins annotated in the Molecular Function, Biological624
Process and Cellular Component ontologies, respectively.625
626
Table S2: The Top-50 studies and the ECO terms we have assigned to them.627
PMID: Articles’ PubMed ID; ECO terms/ECO ID’s: terms and ID’s we assigned to628
the articles.629
630
Table S3: ECO terms were assigned by us to the top-50 annotating papers.631
The table entries are ranked by the frequency of the assignments, i.e. 27 papers are as-632
signed with term ECO:0000160, 21 were assigned ECO:0000004, etc. Entries in boldface633
are for computational methods, which were used in many papers in combination with634
experimental methods to assign function. Table S2 lists the ECO terms.635
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Table S1. Top 50 Annotating Articles
N Proteins Annotations Species ref. MFO BPO CCO
1 4937 11050 H. sapiens [9] 0 0 11050
2 4247 7046 S. pombe [26] 0 0 7046
3 2412 2412 H. sapiens [27] 0 0 2412
4 1791 5918 C. elegans [28] 0 5918 0
5 1406 1863 S. cerevisiae [29] 0 0 1863
6 1251 1251 A. thaliana [30] 0 0 1251
7 1205 1476 C. elegans [31] 0 1476 0
8 1186 1213 M. musculus [32] 0 0 1213
9 1136 1136 A. thaliana [33] 0 0 1136
10 1101 2269 C. elegans [13] 0 2269 0
11 1043 1365 M. tuberculosis [34] 0 0 1365
12 1041 1041 A. thaliana [35] 0 0 1041
13 865 1533 C. elegans [36] 0 1533 0
14 845 845 S. cerevisiae [37] 0 0 845
15 784 784 A. thaliana [38] 0 0 784
16 735 735 M. tuberculosis [39] 0 0 735
17 724 882 A. thaliana [40] 0 0 882
18 634 634 A. thaliana [41] 0 0 634
19 613 613 Mycobacter sp. [42] 0 613 0
20 607 661 C. elegans [16] 0 659 2
21 577 577 A. thaliana [43] 0 0 577
Continued on next page
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N Proteins Annotations Species ref. MFO BPO CCO
22 553 884 C. elegans [11] 0 884 0
23 516 5972 C. elegans [44] 0 5972 0
24 503 503 S. cerevisiae [45] 0 0 503
25 498 638 S. cerevisiae [46] 638 0 0
26 479 848 C. elegans [47] 0 848 0
27 465 468 H. sapiens [48] 0 0 468
28 436 436 A. thaliana [49] 0 0 436
29 430 513 A. thaliana [50] 0 0 513
30 413 456 D. melanogaster [17] 0 39 417
31 401 401 A. thaliana [51] 0 0 401
32 392 392 A. thaliana [52] 0 0 392
33 392 639 C. elegans [15] 0 639 0
34 383 917 C. elegans [12] 0 917 0
35 380 380 A. thaliana [53] 0 0 380
36 375 375 M. musculus [54] 0 0 375
37 343 509 H. sapiens [55] 509 0 0
38 338 338 Ddiscoideum [56] 0 0 338
39 328 328 A. thaliana [57] 0 0 328
40 319 329 C. albicans [58] 1 328 0
41 305 312 A. thaliana [59] 0 0 312
42 290 331 S. cerevisiae [60] 0 0 331
43 285 761 C. elegans [10] 0 761 0
Continued on next page
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N Proteins Annotations Species ref. MFO BPO CCO
44 283 499 C. elegans [61] 0 499 0
45 266 433 M. musculus [62] 433 0 0
46 260 260 A. thaliana [63] 0 260 0
47 258 259 S. pombe [64] 0 259 0
48 244 397 D. melanogaster [14] 0 367 30
49 242 397 D. melanogaster [65] 0 0 397
50 241 263 A. thaliana [66] 0 0 263
The top 50 annotating articles. N: article rank; Proteins: number of proteins636
annotated in this article; Annotations: number of annotating GO terms; Species:637
annotated species; ref. annotating article; MFO/BPO/CCO: number of proteins638
annotated in the Molecular Function, Biological Process and Cellular Component639
ontologies, respectively.640
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Table S2. ECO Terms Assigned to Top-50 Papers
PMID Ref ECO terms/ECO ID’s
18029348 [9] imaging assay evidence/ECO:0000324 immunofluorescence evi-
dence/ECO:0000007 immunolocalization evidence/ECO:0000087
16823372 [26] imaging assay evidence/ECO:0000324 yellow fluorescent protein fu-
sion protein localization evidence/ECO:0000128 enzyme inhibition
experiment evidence/ECO:0000184
18614015 [27] imaging assay evidence/ECO:0000324 protein separation fol-
lowed by fragment identification evidence/ECO:0000160
sequence similarity evidence/ECO:0000044 cell fractiona-
tion evidence/ECO:0000004 GFP fusion protein localization
evidence/ECO:0000126 computational combinatorial evi-
dence/ECO:0000053 motif similarity evidence/ECO:0000028
targeting sequence prediction evidence/ECO:0000081 protein
BLAST evidence/ECO:0000208
14551910 [28] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 nucleotide BLAST evidence/ECO:0000207
sequence alignment evidence/ECO:0000200
14562095 [29] imaging assay evidence/ECO:0000324 GFP fusion protein
localization evidence/ECO:0000126 fusion protein localiza-
tion evidence/ECO:0000124 affinity chromatography evi-
dence/ECO:0000079
Continued on next page
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PMID Ref ECO terms/ECO ID’s
18431481 [30] protein separation followed by fragment identification ev-
idence/ECO:0000160 targeting sequence prediction evi-
dence/ECO:0000081 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 imported informa-
tion/ECO:0000311
15791247 [31] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 protein BLAST evidence/ECO:0000208
14651853 [32] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
targeting sequence prediction evidence/ECO:0000081 se-
quence similarity evidence/ECO:0000044 protein BLAST evi-
dence/ECO:0000208 nucleotide BLAST evidence/ECO:0000207
Affymetrix array experiment evidence/ECO:0000101 imported
information/ECO:0000311
17317660 [33] protein separation followed by fragment identification ev-
idence/ECO:0000160 cell fractionation evidence/ECO:0000004
transmembrane domain prediction evidence/ECO:0000083 se-
quence similarity evidence/ECO:0000044
Continued on next page
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PMID Ref ECO terms/ECO ID’s
12529635 [13] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 motif similarity evidence/ECO:0000028
protein BLAST evidence/ECO:0000208 nucleotide BLAST
evidence/ECO:0000207 computational combinatorial evi-
dence/ECO:0000053
15525680 [34] protein separation followed by fragment identification ev-
idence/ECO:0000160 cell fractionation evidence/ECO:0000004
transmembrane domain prediction evidence/ECO:0000083 se-
quence similarity evidence/ECO:0000044 computational com-
binatorial evidence/ECO:0000053 biological system reconstruc-
tion/ECO:0000088 imported information/ECO:0000311 protein
BLAST evidence/ECO:0000208
21166475 [35] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 computational combina-
torial evidence/ECO:0000053 imported information/ECO:0000311
transmembrane domain prediction evidence/ECO:0000083 se-
quence alignment evidence/ECO:0000200 motif similarity evi-
dence/ECO:0000028
15489339 [36] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 nucleotide BLAST evidence/ECO:0000207
Continued on next page
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16823961 [37] protein separation followed by fragment identification ev-
idence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 imported informa-
tion/ECO:0000311
21533090 [38] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 imported in-
formation/ECO:0000311 computational combinatorial evi-
dence/ECO:0000053 transmembrane domain prediction evi-
dence/ECO:0000083 sequence alignment evidence/ECO:0000200
motif similarity evidence/ECO:0000028 targeting sequence predic-
tion evidence/ECO:0000081
14532352 [39] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 transmembrane domain
prediction evidence/ECO:0000083
20061580 [40] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 transmem-
brane domain prediction evidence/ECO:0000083 imported
information/ECO:0000311 targeting sequence predic-
tion evidence/ECO:0000081 protein expression level evi-
dence/ECO:0000046
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15028209 [41] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 targeting sequence
prediction evidence/ECO:0000081 Affymetrix array exper-
iment evidence/ECO:0000101 protein expression level evi-
dence/ECO:0000046 protein BLAST evidence/ECO:0000208
computational combinatorial evidence/ECO:0000053 motif simi-
larity evidence/ECO:0000028 transmembrane domain prediction
evidence/ECO:0000083
12657046 [42] mutant phenotype evidence/ECO:0000015 nucleic acid hybridiza-
tion evidence/ECO:0000026 imported information/ECO:0000311
sequence similarity evidence/ECO:0000044 combinatorial evi-
dence/ECO:0000212
17704769 [16] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016
17432890 [43] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 transmembrane
domain prediction evidence/ECO:0000083 imported infor-
mation/ECO:0000311 targeting sequence prediction evi-
dence/ECO:0000081 protein BLAST evidence/ECO:0000208
computational combinatorial evidence/ECO:0000053
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11231151 [11] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016
17417969 [44] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016
14576278 [45] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 transmembrane domain
prediction evidence/ECO:0000083
16429126 [46] protein separation followed by fragment identification evi-
dence/ECO:0000160 sequence similarity evidence/ECO:0000044
affinity chromatography evidence/ECO:0000079 protein BLAST
evidence/ECO:0000208 imported information/ECO:0000311
21529718 [47] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype
evidence/ECO:0000016 computational combinatorial evi-
dence/ECO:0000053
11256614 [48] GFP fusion protein localization evidence/ECO:0000126 yellow flu-
orescent protein fusion protein localization evidence/ECO:0000128
imaging assay evidence/ECO:0000324 motif similarity evi-
dence/ECO:0000028 protein BLAST evidence/ECO:0000208 nu-
cleotide BLAST evidence/ECO:0000207
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17644812 [49] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 transmembrane do-
main prediction evidence/ECO:0000083 targeting sequence pre-
diction evidence/ECO:0000081 computational combinatorial evi-
dence/ECO:0000053
16618929 [50] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 transmembrane domain
prediction evidence/ECO:0000083
18433294 [17] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 imaging assay evi-
dence/ECO:0000324 RNAi evidence/ECO:0000019 loss-of-function
mutant phenotype evidence/ECO:0000016 immunofluorescence ev-
idence/ECO:0000007
17151019 [51] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 imported infor-
mation/ECO:0000311 transmembrane domain prediction evi-
dence/ECO:0000083
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14671022 [52] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 protein BLAST
evidence/ECO:0000208 targeting sequence prediction evi-
dence/ECO:0000081
12529643 [15] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016
12445391 [12] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 BLAST evidence/ECO:0000206
15539469 [53] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 targeting sequence pre-
diction evidence/ECO:0000081 transmembrane domain prediction
evidence/ECO:0000083 motif similarity evidence/ECO:0000028
protein BLAST evidence/ECO:0000208 computational combinato-
rial evidence/ECO:0000053
12865426 [54] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 transmembrane domain
prediction evidence/ECO:0000083
Continued on next page
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16189514 [55] yeast 2-hybrid evidence/ECO:0000068 imaging assay evi-
dence/ECO:0000324 motif similarity evidence/ECO:0000028
co-purification evidence/ECO:0000022 combinatorial evi-
dence/ECO:0000212
20422638 [56] protein separation followed by fragment identification ev-
idence/ECO:0000160 cell fractionation evidence/ECO:0000004
sequence similarity evidence/ECO:0000044 combinatorial evi-
dence/ECO:0000212
12938931 [57] protein separation followed by fragment identification evi-
dence/ECO:0000160 cell fractionation evidence/ECO:0000004 se-
quence similarity evidence/ECO:0000044 nucleotide BLAST ev-
idence/ECO:0000207 imported information/ECO:0000311 trans-
membrane domain prediction evidence/ECO:0000083
16336044 [58] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016
18633119 [59] protein separation followed by fragment identification ev-
idence/ECO:0000160 cell fractionation evidence/ECO:0000004
Western blot evidence/ECO:0000112
11914276 [60] imaging assay evidence/ECO:0000324 immunofluorescence evi-
dence/ECO:0000007 epitope-tagged protein immunolocalization
evidence/ECO:0000092 transmembrane domain prediction evi-
dence/ECO:0000083 imported information/ECO:0000311
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11099033 [10] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 protein BLAST evidence/ECO:0000208
computational combinatorial evidence/ECO:0000053
11099034 [61] imaging assay evidence/ECO:0000324 RNAi evi-
dence/ECO:0000019 loss-of-function mutant phenotype evi-
dence/ECO:0000016 nucleotide BLAST evidence/ECO:0000207
protein BLAST evidence/ECO:0000208
11591653 [62] hybrid interaction evidence/ECO:0000025 imaging assay evi-
dence/ECO:0000324
16502469 [63] protein separation followed by fragment identification evi-
dence/ECO:0000160 sequence similarity evidence/ECO:0000044
protein BLAST evidence/ECO:0000208 Northern assay evi-
dence/ECO:0000106 reverse transcription polymerase chain reac-
tion transcription evidence/ECO:0000108
12529438 [64] microarray RNA expression level evidence/ECO:0000104 sequence
orthology evidence used in manual assertion/ECO:0000266 motif
similarity evidence/ECO:0000028
17412918 [14] RNAi evidence/ECO:0000019 loss-of-function mutant phenotype
evidence/ECO:0000016 imaging assay evidence/ECO:0000324
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18981222 [65] protein separation followed by fragment identification evi-
dence/ECO:0000160 sequence similarity evidence/ECO:0000044
protein BLAST evidence/ECO:0000208 in vitro as-
say evidence/ECO:0000181 affinity chromatography evi-
dence/ECO:0000079 imaging assay evidence/ECO:0000324
mutant phenotype evidence/ECO:0000015
16287169 [66] protein separation followed by fragment identification evi-
dence/ECO:0000160 sequence similarity evidence/ECO:0000044
transmembrane domain prediction evidence/ECO:0000083
sequence alignment evidence/ECO:0000200 computational
combinatorial evidence/ECO:0000053 motif similarity ev-
idence/ECO:0000028 targeting sequence prediction evi-
dence/ECO:0000081
The Top-50 studies and the ECO terms we have assigned to them. PMID: Articles’641
PubMed ID; ECO terms/ECO ID’s: terms and ID’s we assigned to the articles.642
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Table S3. Count of ECO terms in top-50 papers
N ECO term ECO ID Articles
1 protein separation followed by fragment iden-
tification evidence
ECO:0000160 27
2 sequence similarity evidence ECO:0000044 27
3 imaging assay evidence ECO:0000324 24
4 cell fractionation evidence ECO:0000004 23
5 transmembrane domain prediction ev-
idence
ECO:0000083 17
6 loss-of-function mutant phenotype evidence ECO:0000016 15
7 protein BLAST evidence ECO:0000208 15
8 RNAi evidence ECO:0000019 15
9 imported information ECO:0000311 13
10 computational combinatorial evidence ECO:0000053 11
11 targeting sequence prediction evidence ECO:0000081 11
12 motif similarity evidence ECO:0000028 10
13 nucleotide BLAST evidence ECO:0000207 7
14 sequence alignment evidence ECO:0000200 4
15 GFP fusion protein localization evidence ECO:0000126 3
16 immunofluorescence evidence ECO:0000007 3
17 affinity chromatography evidence ECO:0000079 3
18 computational combinatorial evidence ECO:0000053 2
19 Affymetrix array experiment evidence ECO:0000101 2
Continued on next page
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20 protein expression level evidence ECO:0000046 2
21 mutant phenotype evidence ECO:0000015 2
22 combinatorial evidence ECO:0000212 2
23 co-purification evidence ECO:0000022 1
24 epitope-tagged protein immunolocalization
evidence
ECO:0000092 1
25 sequence orthology evidence used in
manual assertion
ECO:0000266 1
26 YFP fusion protein localization evidence ECO:0000128 2
27 in vitro assay evidence ECO:0000181 1
28 biological system reconstruction ECO:0000088 1
29 reverse transcription polymerase chain reac-
tion transcription evidence
ECO:0000108 1
30 Northern assay evidence ECO:0000106 1
31 Western blot evidence ECO:0000112 1
32 microarray RNA expression level evidence ECO:0000104 1
33 fusion protein localization evidence ECO:0000124 1
34 BLAST evidence ECO:0000206 1
35 nucleic acid hybridization evidence ECO:0000026 1
36 enzyme inhibition experiment evidence ECO:0000184 1
37 immunolocalization evidence ECO:0000087 1
38 hybrid interaction evidence ECO:0000025 1
39 yeast 2-hybrid evidence ECO:0000068 1
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ECO terms were assigned by us to the top-50 annotating papers. The table entries are643
ranked by the frequency of the assignments, i.e. 27 papers are assigned with term644
ECO:0000160, 21 were assigned ECO:0000004, etc. Entries in boldface are for645
computational methods, which were used in many papers in combination with646
experimental methods to assign function. TableS2 lists the ECO terms.647
